Skip to content
EVE’S SISTERSThe Evolution of a Woman’s Body

Brand-name · Eli Lilly

Orforglipron (Foundayo)

A brand-name, once-daily oral GLP-1 tablet made by Eli Lilly.

Illustration of once-daily oral tablets, not the actual product
Illustration only. The actual product and packaging look different.

Price

From $609 every 28 days

Starter: $609 every 28 days for 3 payments, or $1,399 upfront for 3 months. Maintenance: $689 every 28 days for 3 payments, or $1,849 upfront for 3 months. Includes your first clinician visit.

Your card is authorized at checkout and charged only after a clinician reviews your answers. If treatment isn’t approved, you pay only the consultation fee. Cancellation & refunds

What it is

Orforglipron, sold as Foundayo, is a once-daily oral GLP-1 receptor agonist made by Eli Lilly for weight management. Your clinician will review its approved uses and whether it is right for you.

Brand-name medication.

How it’s used

A tablet taken once a day. Your clinician decides whether it is appropriate and how your plan progresses.

Forms: Daily tablet

  • Starter and maintenance plans

Before you start

  • Requires a clinician evaluation to confirm eligibility.
  • Your clinician will review your health history, current medications, warnings and possible side effects.

Wegovy is a registered trademark of Novo Nordisk. Zepbound, Mounjaro and Foundayo are trademarks of Eli Lilly and Company. Eve’s Sisters is not affiliated with or endorsed by either company. Brand-name medications are dispensed by licensed pharmacies only when a licensed provider prescribes them.

Prescription weight management requires a clinician evaluation to confirm eligibility. Programs are provider-supervised and used alongside nutrition and activity changes. Individual experiences vary.

Prices apply outside North Dakota and Ohio. This page is general information, not medical advice. Talk with a licensed clinician about your own health.